Opioid Overdose

The FDA has granted breakthrough therapy designation to PF614-MPAR, a “next-generation opioid” designed to limit oral overdose potential, according to a press release from its manufacturer.

Physicians who were notified that a patient of theirs had died of an overdose and received a plan with guidance on what to do in the future were less likely to prescribe opioids, a study showed.

Naloxone prescriptions among youth in the United States rose more than 600% from 2017 to 2022, according to findings published in Pediatrics.